[2018 Round-up] Multiple sclerosis in 2018: new therapies and biomarkers

2018 has been a year of substantial progress in multiple sclerosis research, with breakthroughs in experimental medicine and translational research. Advances have ranged from successful clinical trials to new reports of promising biomarkers and improved understanding of the pathophysiology of multiple sclerosis.

Your comment

You are not allowed to add comments!


No comments found!

Select Language

ICNApedia Community Pages

Journal of the International Child Neurology Association

icnapedia vle

ICNC2018 Mumbai India